Quest Diagnostics
825 hedge funds and large institutions have $13.7B invested in Quest Diagnostics in 2023 Q4 according to their latest regulatory filings, with 108 funds opening new positions, 253 increasing their positions, 329 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 793 → 825 (+32)
0.81% more ownership
Funds ownership: 87.6% → 88.41% (+0.81%)
23% less repeat investments, than reductions
Existing positions increased: 253 | Existing positions reduced: 329
Holders
825
Holding in Top 10
2
Calls
$176M
Puts
$78.3M
Top Buyers
| 1 | +$289M | |
| 2 | +$138M | |
| 3 | +$83.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$54.7M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$51.7M |
Top Sellers
| 1 | -$111M | |
| 2 | -$83.5M | |
| 3 | -$56.4M | |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$53.2M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$35.8M |